Cardiology
RSSArticles
-
Transitioning Patients from ECLS to Durable MCS
A registry of patients transitioned from extracorporeal life support to durable mechanical circulatory support was used to derive a tool predicting one-year survival.
-
Paclitaxel-Eluting Devices: Is It Time to Stop Worrying?
Paclitaxel-eluting devices vs. bare metal stents in peripheral arterial disease showed no significant difference in all-cause mortality, contradicting the results of a controversial meta-analysis.
-
Is There an Ideal Time to Administer Antihypertension Medications?
Taking all antihypertensive agents before bed vs. upon awakening in hypertensive patients showed there was less hypertension during sleep and few cardiovascular events over a six-year follow-up.
-
How to Record Reliable Blood Pressure Measurements
A small, community-based study to detect hypertension revealed one week of twice-daily home blood pressure (BP) measurements are more reliable and more accurately predict increased left ventricular mass than clinic or 24-hour ambulatory BP monitoring.
-
Giving the Cold Shoulder to Drug Therapy for Atrial Fibrillation
In two randomized trials published simultaneously, cryoballoon ablation proved superior to drug therapy for prevention of arrhythmia recurrence in patients with paroxysmal atrial fibrillation.
-
Statins as a Protector Against Chemotherapy
Women with early stage breast cancer shield their hearts with cholesterol-lowering drug.
-
Pregnant Women with High Blood Pressure Might Experience Memory Problems
These study participants struggled with thinking and recall exercises 15 years after the pregnancy.
-
Why Does This WCT Change Its Shape?
Imagine there was no history for the ECG shown in the figure. How would one interpret this tracing?
-
Remdesivir Injection and Baricitinib Tablets
Baricitinib/remdesivir should be used to treat suspected or laboratory-confirmed COVID-19 in hospitalized adults and pediatric patients ≥ age 2 years who require supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation.
-
Using Sacubitril/Valsartan to Treat Heart Failure with Preserved Ejection Fraction
An analysis of renal outcomes in the PARAGON-HF trial revealed sacubitril/valsartan slows progression of kidney disease in patients with heart failure with preserved ejection fraction compared to valsartan alone.